Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug information services on a subscription basis

B F Schweigert

    American Journal of Hospital Pharmacy
    |August 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    A hospital-based drug information service (DIS) offers subscription models for hospitals and practitioners. This ensures accessible pharmaceutical information through flexible fee structures, covering staffing, workload, and operational needs.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Pharmacist-managed drug therapy in California hospitals.

    American journal of hospital pharmacy·1989
    Same author

    JCAH survey experience: Memorial Medical Center.

    American journal of hospital pharmacy·1986
    Same author

    Hospital pharmacists as a source of drug information for physicians and nurses.

    American journal of hospital pharmacy·1982
    Same author

    Nitrofurantoin: another cause of drug-induced chronic active hepatitis? A report of a patient with HLA-B8 antigen.

    The American journal of medicine·1979
    Same author

    Neonatal barbiturate withdrawal.

    JAMA·1972

    Area of Science:

    • Pharmaceutical Sciences
    • Health Services Research

    Background:

    • Hospital-based drug information services (DIS) are crucial for providing accurate pharmaceutical data.
    • Establishing sustainable funding models is essential for the continuous operation of DIS.

    Purpose of the Study:

    • To describe the operational and financial model of a hospital-based drug information service.
    • To outline subscription methods for diverse healthcare entities.

    Main Methods:

    • The drug information service (DIS) operates on a subscription basis for five hospitals and a pharmaceutical association.
    • Subscription models include a monthly fee based on hospital bed size or a per-question fee.
    • A flat monthly rate is applied to the pharmaceutical association.

    Related Experiment Videos

    Main Results:

    • The bed-size based fee ensures guaranteed income and unlimited DIS access for hospitals.
    • The per-question fee caters to private practitioners and low-usage hospitals.
    • The flat rate for the pharmaceutical association is covered by membership dues.

    Conclusions:

    • Flexible subscription models can ensure the financial viability of drug information services.
    • These models facilitate broad access to pharmaceutical information for various healthcare providers.